The complex clinical picture of side effects to anticoagulation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Medical clinics of North America

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mcna.2010.03.003PMID 20609865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fondaparinux Sodium

  2012cited by this paper
• Warfarin-induced skin necrosis.

  2009cited by this paper
• Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.

  2009cited by this paper
• Emergence of new oral antithrombotics: a critical appraisal of their clinical potential

  2008cited by this paper
• Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.

  2008cited by this paper
• Outbreak of adverse reactions associated with contaminated heparin.

  2008cited by this paper
• Contaminated heparin associated with adverse clinical events and activation of the contact system.

  2008cited by this paper
• New anticoagulants

  2008cited by this paper
• Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

  2008cited by this paper
• Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Managing Allergy to Heparins

  2006cited by this paper
• Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.

  2006cited by this paper
• Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options

  2006cited by this paper
• Allergy to heparins and anticoagulants with a similar pharmacological profile: an update

  2006cited by this paper
• Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux

  2006cited by this paper
• Direct thrombin inhibitors: pharmacology and clinical relevance

  2005cited by this paper
• Tolerance to intravenous heparin in patients with delayed‐type hypersensitivity to heparins: a prospective study

  2005cited by this paper
• Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study.

  2005cited by this paper
• Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy

  2005cited by this paper
• Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides

  2005cited by this paper
• Heterogeneity of synthetic factor Xa inhibitors.

  2005cited by this paper
• Intolerance of fondaparinux in a patient allergic to heparins

  2004cited by this paper
• Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy

  2004cited by this paper
• Delayed‐type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration

  2004cited by this paper
• Treatment of 51 pregnancies with danaparoid because of heparin intolerance

  2004cited by this paper
• Delayed‐type hypersensitivity to the ultra‐low‐molecular‐weight heparin fondaparinux

  2004cited by this paper
• The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Treatment of heparin-induced thrombocytopenia: a critical review.

  2004cited by this paper
• Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced Thrombocytopenia

  2003cited by this paper
• Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair.

  2003cited by this paper
• Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.

  2003cited by this paper
• How I treat heparin-induced thrombocytopenia and thrombosis.

  2003cited by this paper
• Extensive skin necrosis associated with warfarin sodium therapy.

  2003cited by this paper
• Enoxaparin-induced generalized exanthem.

  2003cited by this paper
• Generalized eczema induced by nadroparin.

  2003cited by this paper
• Management of venous thromboembolism: past, present, and future.

  2003cited by this paper
• Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans

  2003cited by this paper
• The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif—the C‐domain

  2003cited by this paper
• An overview of antithrombotic therapy

  2002cited by this paper
• Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin.

  2002cited by this paper
• Arthus reaction to lepirudin, a new recombinant hirudin, and delayed‐type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration

  2002cited by this paper
• Platelets and thrombin generation.

  2002cited by this paper
• Direct thrombin inhibitors.

  2002cited by this paper
• The new ID‐heparin/PF4 antibody test for rapid detection of heparin‐induced antibodies in comparison with functional and antigenic assays

  2002cited by this paper
• ABC of antithrombotic therapy: An overview of antithrombotic therapy.

  2002cited by this paper
• Temporal aspects of heparin-induced thrombocytopenia.

  2001cited by this paper
• Delayed‐Type Hypersensitivity and Cross‐Reactivity to Heparins and Danaparoid: A Prospective Study

  2001cited by this paper
• Heparin-Induced Skin Necrosis in a Patient with End-Stage Renal Failure and Functional Protein S Deficiency

  2001cited by this paper
• Emergency cardiopulmonary bypass in a bilaterally nephrectomized patient with a history of heparin-induced thrombocytopenia: successful reexposure to heparin.

  2001cited by this paper
• Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.

  2001cited by this paper
• Warfarin induced skin necrosis

  2000cited by this paper
• Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia.

  2000cited by this paper
• Intravenous challenge with heparins in patients with delayed‐type skin reactions after subcutaneous administration of the drug

  1998cited by this paper
• Delayed‐type hypersensitivity to subcutaneous enoxaparin

  1998cited by this paper
• Platelets of patients with peripheral arterial disease are hypersensitive to heparin.

  1996cited by this paper
• Tolerance to intravenous admiration of heparin and heparinoid in a patient with delayed‐type hypersensitivity to heparins and heparinoids

  1996cited by this paper
• Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction.

  1996cited by this paper
• Reinstituting warfarin in patients who develop warfarin skin necrosis

  1996cited by this paper
• Coumadin Necrosis of the Skin: Report of Four Patients

  1996cited by this paper
• [Skin necrosis: a paradoxical complication of anticoagulation].

  1995cited by this paper
• [Allergic drug exanthema to heparin. Cutaneous reactions to high molecular and fractionated heparin].

  1994cited by this paper
• Contamination of heparin by histamine: measurement and characterization by high‐performance liquid chromatography and radioimmunoassay

  1994cited by this paper
• Heparin skin necrosis—an important indicator of potentially fatal heparin hypersensitivity

  1993cited by this paper
• Heparin‐associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides

  1993cited by this paper
• Warfarin-induced skin necrosis in 2 patients with protein S deficiency: successful reinstatement of warfarin therapy.

  1992cited by this paper
• Influence of skinfold thickness on heparin absorption.

  1991cited by this paper
• Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction

  1990cited by this paper
• Generalized reaction to subcutaneous heparin

  1989cited by this paper
• Eczema-like, erythematous, infiltrated plaques: a common side effect of subcutaneous heparin therapy.

  1989cited by this paper
• Eczema as a complication of heparin therapy.

  1989cited by this paper
• Delayed‐type hypersensitivity reaction to heparin

  1989cited by this paper
• Heparin necrosis: an anticoagulant-induced cutaneous infarct.

  1982cited by this paper
• Cutaneous necrosis caused by systemically administered heparin.

  1981cited by this paper

• Anticoagulation Therapy for Venous Thromboembolism.

  2025cites this paper
• Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management

  2024cites this paper
• Approach to the Atypical Wound

  2024cites this paper
• Inflammatory and vaso-occlusive ulcers: Part I - clinical presentation and diagnosis.

  2024cites this paper
• Heparin Allergy: Frequently Suspected, Seldom Proven, and Easily Circumvented.

  2022cites this paper
• Delayed-type heparin allergy: intravenous tolerance despite inflammatory skin reaction after subcutaneous injection.

  2022cites this paper
• Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.

  2021cites this paper
• Pharmacologic Treatment of Pulmonary Embolism

  2021cites this paper
• Pharmacologic Impact (aka "Breaking Bad") of Medications on Wound Healing and Wound Development: A Literature-based Overview.

  2017cites this paper
• Poly(γ-glutamic acid), coagulation? Anticoagulation?

  2016cites this paper
• Hypersensitivity reactions to heparins

  2016cites this paper
• An Approach to Heparin and Lidocaine Hypersensitivity for the Interventional Nephrologist

  2014influential citation
• Allergic anaphylaxis due to subcutaneously injected heparin

  2013cites this paper
• Recurrent intradialytic heparin induced anaphylaxis: workup and management

  2013cites this paper
• Agents for the Management of Hematologic Reactions

  2013cites this paper
• Heparin - A Century of Progress

  2012cites this paper
• Adverse effects of heparin.

  2012cites this paper
• Livedoid vasculopathy: an intringuing cutaneous disease.

  2011cites this paper
• Differenzialdiagnosen und Therapie des Ulcus cruris

  2011cites this paper
• Livedoid vasculopathy: an intringuing cutaneous disease * Vasculopatia livedoide: uma doença cutânea intrigante

  2011cites this paper
• Livedoid vasculopathy as a coagulation disorder.

  2011cites this paper
• Differential diagnosis and therapy of leg ulcers

  2011cites this paper
• Vasculopatia livedoide: uma doença cutânea intrigante

  2011cites this paper